Violation Tracker Individual Record
Company:Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc.
Date:July 10, 2009
Offense Group:government-contracting-related offenses
Primary Offense:False Claims Act and related
Subsidiaries of Boehringer Ingelheim GmbH agreed to pay $4.5 million in settlement of alleged improper reporting of the average wholesale price of its drugs, causing Medicaid to overpay.
Level of Government:state
Action Type:agency action
Agency:Kentucky Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:Germany
Ownership Structure of Parent:privately held
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.